MELVILLE, N.Y. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) and AVEO Pharmaceuticals, Inc. today announced that they have expanded the drug discovery and translational research
For more information, please visit
http://www.businesswire.com/news/home/20090721005670/en